Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea.

Sojung Han,Do Young Kim,Ho Yeong Lim,Jung-Hwan Yoon,Baek-Yeol Ryoo,Yujeong Kim, Kookhee Kim,Bo Yeon Kim,So Young Yi,Dong-Sook Kim,Do-Yeon Cho, Jina Yu,Suhyun Kim,Joong-Won Park

Gut and liver（2023）

引用 0|浏览6

暂无评分

摘要

Real-life data show that the efficacy of sorafenib seems similar to that observed in clinical trials, suggesting that appropriate subsequent therapy after sorafenib might prolong patient survival.

查看译文

关键词

Carcinoma, hepatocellular, Sorafenib, Survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要